Dare Bioscience shares are trading lower after the company announced a 1-for-12 reverse stock split.
Portfolio Pulse from Benzinga Newsdesk
Dare Bioscience shares are trading lower following the announcement of a 1-for-12 reverse stock split.
June 27, 2024 | 12:53 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Dare Bioscience shares are trading lower after the company announced a 1-for-12 reverse stock split.
Reverse stock splits are often perceived negatively by investors as they can indicate underlying financial issues. This announcement has led to a decline in Dare Bioscience's share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100